Dr. Martens plc

LSE DOCS.L

Dr. Martens plc Price to Earnings Ratio (P/E) on January 14, 2025: 8.84

Dr. Martens plc Price to Earnings Ratio (P/E) is 8.84 on January 14, 2025, a 39.79% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Dr. Martens plc 52-week high Price to Earnings Ratio (P/E) is 13.86 on April 04, 2024, which is 56.84% above the current Price to Earnings Ratio (P/E).
Dr. Martens plc 52-week low Price to Earnings Ratio (P/E) is 5.82 on January 19, 2024, which is -34.19% below the current Price to Earnings Ratio (P/E).
Dr. Martens plc average Price to Earnings Ratio (P/E) for the last 52 weeks is 9.38.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

LSE: DOCS.L

Dr. Martens plc

CEO	Mr. Kenneth Wilson
IPO Date	Jan. 29, 2021
Location	United Kingdom
Headquarters	28 Jamestown Road
Employees	2,630
Sector	Consumer Discretionary
Industries Footwear

Description

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Key trends

Past 5 years